The Efficacy of Five Years of Treatment with Omalizumab for a Patient with Severe Persistent Asthma

Abstract

Even though asthma patients are treated with anti-asthma agents, some patients do not respond very well to them. In our study, we treated a 66-year-old woman who had been suffering from asthma for 26 years. She had been receiving treatment up to Step 4 of the Asthma Prevention and Management Guidelines, but her respiratory symptoms had not improved. We found that treatment with omalizumab yielded no improvement for lung function; however, the number of her emergency visits and dosage of methylprednisolone showed significant reductions compared to the previous year. Thus, with omalizumab, the patient was stabilized at an early treatment stage.